Rapport Therapeutics, Inc. (RAPP)
26.07
+1.63
(+6.67%)
USD |
NASDAQ |
Nov 09, 16:00
26.03
-0.04
(-0.15%)
After-Hours: 20:00
Rapport Therapeutics Price to Book Value : 3.205 for Nov. 9, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 09, 2026 | 3.205 |
| November 06, 2026 | 3.004 |
| November 05, 2026 | 2.916 |
| November 04, 2026 | 3.188 |
| November 03, 2026 | 3.127 |
| November 02, 2026 | 3.089 |
| October 30, 2026 | 3.079 |
| October 29, 2026 | 2.976 |
| October 28, 2026 | 2.766 |
| October 27, 2026 | 3.386 |
| October 26, 2026 | 3.114 |
| October 23, 2026 | 3.188 |
| October 22, 2026 | 3.261 |
| October 21, 2026 | 3.081 |
| October 20, 2026 | 3.610 |
| October 19, 2026 | 3.516 |
| October 16, 2026 | 3.389 |
| October 15, 2026 | 3.635 |
| October 14, 2026 | 3.483 |
| October 13, 2026 | 3.564 |
| October 12, 2026 | 3.706 |
| October 09, 2026 | 3.768 |
| October 08, 2026 | 3.669 |
| October 07, 2026 | 3.794 |
| October 06, 2026 | 3.829 |
| Date | Value |
|---|---|
| October 05, 2026 | 3.957 |
| October 02, 2026 | 3.955 |
| October 01, 2026 | 4.036 |
| September 30, 2026 | 4.130 |
| September 29, 2026 | 3.744 |
| September 28, 2026 | 3.792 |
| September 25, 2026 | 3.845 |
| September 24, 2026 | 3.836 |
| September 23, 2026 | 3.87 |
| September 22, 2026 | 4.702 |
| September 21, 2026 | 4.497 |
| September 18, 2026 | 4.587 |
| September 17, 2026 | 4.757 |
| September 16, 2026 | 4.693 |
| September 15, 2026 | 4.839 |
| September 14, 2026 | 4.989 |
| September 11, 2026 | 4.946 |
| September 10, 2026 | 4.928 |
| September 09, 2026 | 4.976 |
| September 08, 2026 | 5.226 |
| September 04, 2026 | 5.190 |
| September 03, 2026 | 5.403 |
| September 02, 2026 | 5.521 |
| September 01, 2026 | 5.506 |
| August 31, 2026 | 5.519 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Johnson & Johnson | 8.329 |
| ANI Pharmaceuticals, Inc. | 2.437 |
| Corcept Therapeutics, Inc. | 9.841 |
| Veru, Inc. | 1.316 |
| Eli Lilly & Co. | 33.00 |
Price to Book Value Related Metrics
| PS Ratio | 61.74 |
| PEG Ratio | -0.4593 |
| Price | 26.07 |
| Earnings Yield | -12.17% |
| Market Cap | 1.254B |
| PEGY Ratio | -0.4593 |